Valuation Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
09:05:07 11/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 2,754.90 INR | -1.45% |
|
-3.17% | +49.88% |
| 15/08 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 12/08 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Company Valuation: Caplin Point Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 51,529 | 45,291 | 100,038 | 152,221 | 114,409 | 209,393 | - |
| Change | - | -12.11% | 120.88% | 52.16% | -24.84% | 83.02% | - |
| Enterprise Value (EV) | 51,529 | 45,291 | 100,038 | 152,221 | 114,409 | 209,393 | 209,393 |
| Change | - | -12.11% | 120.88% | 52.16% | -24.84% | 83.02% | 0% |
| P/E | 17.3x | 12.1x | 22x | 28.5x | 17.9x | 28.8x | 24.9x |
| PBR | 3.47x | 2.41x | 4.32x | 5.34x | 3.19x | 4.74x | 4.29x |
| PEG | - | 0.5x | 1x | 1.6x | 0.9x | 2.1x | 1.6x |
| Capitalization / Revenue | 4.06x | 3.09x | 5.91x | 7.86x | 5.23x | 8.35x | 7.39x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 8.35x | 7.39x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 24.1x | 20.8x |
| EV / EBIT | 0x | 0x | - | 0x | 0x | 22.5x | 19.5x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 37.7x | 37.1x |
| FCF Yield | 4.77% | 1.72% | 1.73% | 1.58% | 2.4% | 2.65% | 2.69% |
| Dividend per Share 2 | 2 | 2 | 2.5 | 3 | - | 4 | 4 |
| Rate of return | 0.29% | 0.34% | 0.19% | 0.15% | - | 0.15% | 0.15% |
| EPS 2 | 39.26 | 49.18 | 59.9 | 70.25 | 84.11 | 95.6 | 110.7 |
| Distribution rate | 5.09% | 4.07% | 4.17% | 4.27% | - | 4.18% | 3.61% |
| Net sales 1 | 12,694 | 14,667 | 16,941 | 19,375 | 21,872 | 25,072 | 28,340 |
| EBITDA 1 | 3,947 | 4,411 | 5,514 | 6,469 | 7,609 | 8,700 | 10,050 |
| EBIT 1 | 3,478 | 4,520 | - | 5,810 | 8,036 | 9,321 | 10,752 |
| Net income 1 | 2,998 | 3,763 | 4,571 | 5,363 | 6,412 | 7,264 | 8,411 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 679.90 | 596.70 | 1,317.30 | 2,002.60 | 1,505.15 | 2,754.75 | 2,754.75 |
| Nbr of stocks (in thousands) | 75,789 | 75,903 | 75,942 | 76,012 | 76,012 | 76,012 | - |
| Announcement Date | 12/5/22 | 27/5/23 | 16/5/24 | 15/5/25 | 14/5/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 34.34x | 6.44x | 22.32x | 0.92% | 46.7B | |
| 16.44x | 2.03x | 9.03x | 1.61% | 39.11B | |
| 26.8x | 3.83x | 15.89x | 0.6% | 11.66B | |
| 26.73x | 3.24x | 16.77x | 0.95% | 11.6B | |
| 18.66x | 3.39x | 11.8x | 3.78% | 9.19B | |
| 9.19x | 2.12x | 5.48x | 4.83% | 7.27B | |
| 29.37x | 3.84x | 17.87x | 0.16% | 7.13B | |
| 15.11x | 1.96x | 6.53x | 3.34% | 7.15B | |
| Average | 22.08x | 3.36x | 13.21x | 2.02% | 17.48B | |
| Weighted average by Cap. | 24.50x | 3.94x | 15.01x | 1.56% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CAPLIPOINT Stock
- CAPLIPOINT Stock
- Valuation Caplin Point Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
